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ABSTRACT  
Background: Limited studies are available on the clinical significance of left ventricular lead 
polarity in patients undergoing cardiac resynchronization (CRT), with a recent study 
suggesting better outcomes with LV true bipolar pacing.  
Objectives: We aimed to determine whether True-Bipolar LV pacing is associated with 
reduced mortality in a large, real-life CRT cohort, followed by remote monitoring.  
Methods: We analyzed de-identified device data from CRT patients followed by the Boston 
Scientific LATITUDE remote monitoring database system. Patients with LV bipolar leads 
paced between the LV ring and LV tip were identified as True-Bipolar and those with LV 
bipolar leads paced between LV tip or LV ring to RV coil were identified as Extended 
Bipolar.  Patients with unipolar leads were identified as Unipolar.  
Results: Of the 59,046 patients included in the study, 2,927 had Unipolar pacing, 34,390 had 
Extended Bipolar pacing, and 21,729 had True-Bipolar pacing. LV True-Bipolar pacing was 
associated with a significant 30% lower risk of all-cause mortality as compared to unipolar 
pacing (HR=0.70, 95% CI: 0.62-0.79, p<0.001), after adjustment for age, gender, LV lead 
impedance, LV pacing threshold, and BIV pacing percentage<95%. Extended-Bipolar LV 
pacing was also associated with 24% lower risk of all-cause mortality when compared to 
Unipolar LV pacing (HR=0.76, 95% CI: 0.68-0.85; p<0.001). However, there were no 
differences in outcomes between True-Bipolar or Extended-Bipolar LV pacing (HR=0.97, 
95% CI: 0.93-1.01; p=0.198). 
Conclusion: True-Bipolar and Extended-Bipolar LV pacing is associated with a lower risk of 
mortality in cardiac resynchronization therapy patients as compared to Unipolar LV pacing. 
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INTRODUCTION 
Cardiac resynchronization (CRT) is the standard of care treatment for the management of 
advanced heart failure patients with severely reduced left ventricular function, and a wide 
QRS.
1-5
 Optimized delivery of CRT is linked to significant left ventricular reverse 
remodeling, improvement in cardiac function, and output.
6
 Successful delivery of CRT is 
however dependent on multiple factors, including left ventricular (LV) lead location, scar 
location and extent, and device programming, including modifiable parameters.  
 LV lead pacing polarity is a poorly studied, modifiable parameter in CRT devices that 
might impact clinical outcomes. In a recent sub-study of the Multicenter Automatic 
Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT),
7
 we 
demonstrated that mild heart failure (HF), LBBB patients undergoing CRT had a 
significantly lower risk of all-cause mortality with bipolar LV pacing compared to unipolar 
pacing. We suspect our finding is secondary to a more homogenous activation of the left 
ventricle and reduction in mechanical dyssynchrony by bipolar LV pacing. While these data 
from our subgroup analysis are hypothesis generating and promising, further testing in a 
large, real-life cohort are warranted to validate our findings. The ALTITUDE registry is one 
of the largest remote monitoring database providing real-life data on a large cohort of ICD 
and CRT-D patients, and capturing LV lead pacing polarity (Boston Scientific Corp, Natick, 
MA). 
Given the clinical significance of this easily modifiable parameter and paucity of data 
on associated cardiovascular outcomes, we aimed to further study LV lead pacing polarity in 
a larger patient population. This study was designed to assess the association of LV lead 
pacing polarity and all-cause mortality in a large cohort of CRT-D patients participating in 
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METHODS 
Study Population 
The ALTITUDE registry was established in 2008 to prospectively analyze data from ICD and 
cardiac resynchronization therapy (CRT-D) devices followed through the LATITUDE 
clinical remote monitoring system (Boston Scientific Corp, Natick, MA). LATITUDE earned 
U.S. Food and Drug Administration approval in 2005, and since 2006, all new Boston 
Scientific ICD and CRT-D implants have been eligible for enrollment in this remote follow-
up network. The remote interrogations may be patient initiated or performed automatically by 
wireless telemetry. Data are then transferred by telephone line and are accessible for routine 
clinical care through a secure website administered by Boston Scientific. The decision to 
enroll a patient in the remote follow-up system is made by the implanting physician at the 
time of device implantation or at routine post-implantation follow-up clinic visits.  
De-identified data from the LATITUDE network form the data set for ALTITUDE 
studies. Investigator-initiated proposals to ALTITUDE are reviewed by an independent 
physician panel and projects with scientific merit are supported. Several previous studies 




Patients enrolled in the LATITUDE system were eligible in this study if they had 
been implanted with a first CRT-D device, and they had information available on LV lead 
pacing polarity. Patients with not first CRT-D implant, those implanted before 2011, and 
those with missing follow-up were excluded from the current analysis (Figure 1). Therefore, 
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Device Programming 
Data reported in this study reflect the programming at the time of implantation. Left 
ventricular lead selection, and LV lead pacing polarity programming were left to the 
discretion of the implanting physician.   
Definitions, Follow-up, and End Points 
Left Ventricular pacing polarity was determined based on enrollment data collected by the 
LATTITUDE System. Patients with LV bipolar leads paced between LV-ring and LV-tip 
were identified as True-bipolar. Those with LV bipolar leads programmed to pace between 
LV tip or LV ring and RV coil were identified as Extended-Bipolar. Unipolar LV lead pacing 
was assessed as a separate sub-group. All-cause mortality was the primary end point of this 
study. De-identified patient clinical status, including death, was collected by Boston 
Scientific. Mean follow-up duration was 3.3 ± 1.6 years. 
Statistical analysis 
Available baseline clinical demographics, as appropriate, were compared between True-
Bipolar, Extended-Bipolar and Unipolar patients using analysis of variance (ANOVA) for 
continuous variables and 
2 
- test for dichotomous variables. Kaplan-Meier method was used 
to demonstrate the cumulative probability of all-cause mortality by baseline LV lead pacing 
polarity. The log-rank test was used to compare respective cumulative rates.  
Multivariate Cox proportional hazards regression analysis was used and adjusted for 
relevant clinical covariates. All statistical tests were two-sided, and a p-value of <0.05 was 
considered statistically significant. Analyses were carried out with the SAS software, version 
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RESULTS 
Clinical Characteristics of Patients 
More than half of the patients (58%) enrolled in this study had Extended-Bipolar LV pacing 
(34,390), while 37% of the patients were True-Bipolar paced (21,729), and only 5% had 
unipolar LV pacing (2,927). True-Bipolar LV paced patients were interestingly less likely 
females (26.6% vs. 29.8% vs. 29.2%), and they had a lower LV pacing threshold (1.3 V vs. 
1.5 V vs. 1.5 V), at a shorter pulse width, and a higher LV lead impedance (868 Ohm vs. 584 
Ohm vs. 603 Ohm) than patients with extended bipolar or unipolar LV pacing. In addition, 
patients with true-bipolar LV pacing were more likely to have less than 95% biventricular 
pacing (24.3% vs. 23.2% vs. 19.5%), as compared to patients with extended bipolar LV 
pacing and unipolar LV pacing (Table 1).  
Risk of Mortality with True-Bipolar LV Pacing vs. Unipolar LV Pacing 
Patients with True-Bipolar LV pacing had a significantly lower cumulative probability of all-
cause mortality as compared to patients with Unipolar LV pacing (p<0.0001, Figure 2). It is 
relevant to note that the difference emerges after one year of follow-up. Multivariate Cox 
proportional hazards regression model after adjustment for age, gender, LV lead impedance, 
LV pacing threshold, and BIV pacing <95%, showed that LV true bipolar pacing was 
associated with a significant 28% reduction in all-cause mortality when compared to unipolar 
LV pacing (HR=0.72, 95% CI: 0.62-0.79, p<0.001) (Table 2). 
Risk of Mortality with Extended-Bipolar LV Pacing vs. Unipolar LV Pacing 
Similarly, CRT-D patients with Extended-Bipolar LV pacing had a significantly lower 
cumulative probability of all-cause mortality compared to Unipolar LV paced patients 
(p=0.0005, Figure 3). Similarly, this difference emerges after one year of follow-up. After 
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95%, Extended-Bipolar LV pacing was associated with a 24% lower mortality when 
compared to LV unipolar pacing (HR=0.76, 95% CI: 0.68-0.85; p<0.001) (Table 2).  
Risk of Mortality with True-Bipolar LV Pacing vs. Extended-Bipolar LV Pacing 
Interestingly, we found no differences in the risk of all-cause mortality between True-Bipolar 
and Extended-Bipolar LV paced patients (Figure 4), even after adjustment for age, gender, 
LV lead impedance, LV pacing threshold, and BIV pacing percentage less than 95% 
(HR=0.97, 95% CI: 0.93-1.01; p=0.198) (Table 2). 
 
DISCUSSION 
In our study, we demonstrate that in a large cohort of real-life CRT-D patients enrolled in the 
LATITUDE database, both True-Bipolar or Extended-Bipolar LV pacing was associated with 
a significantly lower risk of all-cause mortality when compared to patients with Unipolar LV 
pacing. Unipolar LV pacing was infrequent (5%), and patients with unipolar LV pacing 
presented with a higher LV pacing threshold, and lower LV lead impedance. Altogether, 
these findings indicate that true bipolar or extended bipolar LV pacing is linked to better 
outcomes in CRT-D than unipolar LV pacing, and unipolar LV pacing should be avoided 
whenever possible. 
The selection of LV lead size and polarity is typically made at the time of CRT 
implantation, and it is dependent on physician preference, native coronary sinus anatomy, 
reducing the incidence of diaphragmatic stimulation, or avoiding high pacing threshold. 
Clinician preferences also play a significant role, and local practice patterns can at times 
dictate lead selection. Importantly, once programmed at implantation, reprogramming is 
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A small prior study had recently demonstrated that ventricular activation sequence of 
the left ventricle is dependent on pacing polarity.
12
 In addition, we have also demonstrated in 
a MADIT-CRT sub-study, that CRT-D patients with True-Bipolar LV lead pacing polarity 
have a significantly lower risk of all-cause mortality and heart failure/death as compared to 
those with Unipolar and Extended-Bipolar LV pacing.
13
 However, MADIT-CRT was a 
randomized clinical trial conducted in mild HF patients, and therefore, these findings cannot 
be fully generalized to the overall CRT-D population. Therefore, our current study further 
extends previous findings by demonstrating in a very large CRT-D cohort, presumptively 
including both mild and advanced HF patients, that true or extended bipolar LV pacing is 
associated with a lower mortality risk when compared to Unipolar LV pacing. This has 
significant relevance for clinical practice, suggesting that LV unipolar pacing should be 
avoided whenever possible. 
When would we typically use LV unipolar pacing? Unipolar LV pacing has been 
useful in cases with high LV pacing thresholds in an effort to improve battery longevity. 
However, high left ventricular pacing threshold could be potentially present when the lead is 
implanted in a scar region in the context of CRT, as shown in a previous MADIT-CRT sub-
study.
14
 In addition, pacing from scar regions in CRT-D patients has been linked to worse 
clinical outcomes.
15
 In addition, as our current study suggests, unipolar pacing is linked to 
worse survival, even when we adjust our models for LV pacing threshold. Therefore, bipolar 
LV pacing should be considered in such cases to improve outcomes, especially since newer 
devices have better device longevity even with higher pacing voltages. 
How can we explain out current findings? As we previously suggested, LV bipolar 
pacing and extended bipolar pacing may results in more homogenous activation of the left 
ventricle,
12
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been shown to be associated with better outcomes.
16, 17
 However, these prior findings on 
more homogenous LV activation have never been confirmed in a large cohort of CRT-D 
patients, like in our study. It might also be possible, that the selection of LV unipolar pacing 
polarity is linked to other characteristics such as scar in the selected LV lead area, and serves 
as a surrogate marker rather than representing a causal relationship. Such an association 
cannot be fully excluded in our current study, therefore, prospective, randomized studies 
would be useful to ascertain the effects of LV unipolar vs. bipolar pacing in CRT-D patients.  
We believe our findings have important clinical implications for the programming of 
LV pacing polarity in CRT-D patients. Our data from both MADIT-CRT and ALTITUDE 
serve a strong case for avoiding LV unipolar pacing in CRT-D patients whenever possible. 
By better programming of LV lead pacing polarity, patients may derive better outcomes from 
CRT-D.  
Our current study has certain limitations. This is a post-hoc analysis, LV lead pacing 
polarity programming was not randomized, and it could be influenced by patient 
characteristics and physician preferences. Due to the patient population and study design, we 
were unable to perform analysis by baseline QRS morphology. Therefore, this current study 
thus may include patients who derived less clinical benefit from CRT-D. Nevertheless, this is 
still one of the largest cohorts to date with data available on LV lead pacing polarity and 
outcomes. 
CONCLUSIONS 
In a large cohort of cardiac resynchronization therapy patients from the ALTITUDE study, 
True-Bipolar and Extended-Bipolar LV pacing was associated with a significantly lower risk 




This article is protected by copyright. All rights reserved. 
10 | P a g e  
extended bipolar LV lead pacing polarity could be favored over unipolar LV pacing in 
cardiac resynchronization therapy patients to improve outcomes whenever feasible. 
 
REFERENCES  
[1] Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-
resynchronization therapy with or without an implantable defibrillator in advanced chronic 
heart failure. The New England journal of medicine 2004; 350: 2140-2150. 
[2] Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. 
The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New 
England journal of medicine 2005; 352: 1539-1549. 
[3] Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-
resynchronization therapy for the prevention of heart-failure events. The New England 
journal of medicine 2009; 361: 1329-1338. 
[4] Al-Khatib SM, Stevenson WG, Ackerman MJ, Gillis AM, Bryant WJ, Hlatky MA, et 
al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular 
Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of 
the American College of Cardiology/American Heart Association Task Force on Clinical 
Practice Guidelines and the Heart Rhythm Society. Heart rhythm 2017. 
[5] Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. 
The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New 
England journal of medicine 2005; 352: 1539-1549. 
[6] Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, et al. Effect of 
cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter 
automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation 




This article is protected by copyright. All rights reserved. 
11 | P a g e  
[7] Kutyifa V MA, Stein K, Wang PJ, Musat D, Jones P, Wehrenberg S. True Bipolar 
Left Ventricular Pacing is Associated With Better Survival in Cardiac Resynchronization 
Therapy Patients. Circulation 2015; 132: A15501. 
[8] Kramer DB, Mitchell SL, Monteiro J, Jones PW, Normand SL, Hayes DL, et al. 
Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: 
The ALTITUDE Activity Study. Journal of the American Heart Association 2015; 4. 
[9] Cronin EM, Jones P, Seth MC, Varma N. Right Ventricular Pacing Increases Risk of 
Appropriate Implantable Cardioverter-Defibrillator Shocks Asymmetrically: An Analysis of 
the ALTITUDE Database. Circulation Arrhythmia and electrophysiology 2017; 10. 
[10] Kramer DB, Jones PW, Rogers T, Mitchell SL, Reynolds MR. Patterns of physical 
activity and survival following cardiac resynchronization therapy implantation: the 
ALTITUDE activity study. Europace : European pacing, arrhythmias, and cardiac 
electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and 
cardiac cellular electrophysiology of the European Society of Cardiology 2017; 19: 1841-
1847. 
[11] Steinberg BA, Wehrenberg S, Jackson KP, Hayes DL, Varma N, Powell BD, et al. 
Atrioventricular and ventricular-to-ventricular programming in patients with cardiac 
resynchronization therapy: results from ALTITUDE. J Interv Card Electrophysiol 2015; 44: 
279-287. 
[12] Yang HS, Caracciolo G, Sengupta PP, Goel R, Chandrasekaran K, Srivathsan K. 
Pacing polarity and left ventricular mechanical activation sequence in cardiac 
resynchronization therapy. J Interv Card Electrophysiol 2012; 35: 101-107. 
[13] Jame S, Kutyifa V, Aktas MK, McNitt S, Polonsky B, Al-Ahmad A, et al. Bipolar left 
ventricular pacing is associated with significant reduction in heart failure or death in CRT-D 




This article is protected by copyright. All rights reserved. 
12 | P a g e  
[14] Pires LA, McNitt S, Solomon S, Goldenberg I, Zareba W, Moss AJ. Left ventricular 
pacing threshold and outcome in MADIT-CRT. Journal of cardiovascular electrophysiology 
2014; 25: 1005-1011. 
[15] Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Arnold CT, et al. 
Relative merits of left ventricular dyssynchrony, left ventricular lead position, and 
myocardial scar to predict long-term survival of ischemic heart failure patients undergoing 
cardiac resynchronization therapy. Circulation 2011; 123: 70-78. 
[16] Knappe D, Pouleur AC, Shah AM, Cheng S, Uno H, Hall WJ, et al. Dyssynchrony, 
contractile function, and response to cardiac resynchronization therapy. Circulation Heart 
failure 2011; 4: 433-440. 
[17] Kutyifa V, Pouleur AC, Knappe D, Al-Ahmad A, Gibinski M, Wang PJ, et al. 
Dyssynchrony and the risk of ventricular arrhythmias. JACC Cardiovascular imaging 2013; 
6: 432-444. 
FIGURE LEGENDS 






This article is protected by copyright. All rights reserved. 
13 | P a g e  
Figure 2. Cumulative Probability of All-Cause Mortality in CRT-D patients with True-
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Figure 3. Cumulative Probability of All-Cause Mortality in CRT-D patients with Extended-
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Figure 4. Cumulative Probability of All-Cause Mortality in CRT-D patients with True-
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Table 1. Baseline Clinical Characteristics of Patients enrolled in the LATITUDE database 
included in this study 
Clinical Characteristics Unipolar Extended-Bipolar True-Bipolar 
Number of patients 2,927 34,390 21,729 
Age at enrollment (years) 73.8 ± 11.1 75.2 ± 10.9 74.4 ± 11.5* 
Female, n (%) 873 (29.8)  10053 (29.2) 5788 (26.6)* 
LV Lead Impedance (Ohm) 603 ± 191 584 ± 192 868 ± 267 * 
LV Lead Intrinsic Amplitude 
(V) 
12.7 ± 6.1 12.4 ± 6.5 13.4 ± 6.9 
LV Pacing Threshold (V) 1.5 ±1.2 1.5 ± 1.2 1.3 ± 0.9* 
LV Pacing Pulse Width (ms) 0.81 ± 0.45 0.72 ± 0.40 0.62 ± 0.32* 
BIV pacing < 95% (%) 19.5 23.2 24.3* 
 
*indicates p< 0.05 for comparison between true bipolar vs. unipolar vs. extended bipolar LV 
pacing 
**These data were collected at the first data upload at an average of 33 weeks after implant. 
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HR 95% CI p-value 
True-Bipolar vs. Unipolar 0.72 0.62-0.79 <0.001 
Extended-Bipolar vs. Unipolar 0.76 0.68-0.85 <0.001 
True-Bipolar vs. Extended Bipolar 0.97 0.93-1.01 0.198 
 
HR, hazard ratio; 95% CI, 95% confidence interval.  
Models were adjusted for the following covariates: age, gender, LV lead impedance, LV 
pacing threshold, and BIV pacing percentage<95%. 
 
 
 
 
 
 
